SOURCE: AVL Global, Inc.

October 06, 2005 10:19 ET

AVL Global Signs Merger Documents

PORT HURON, MI -- (MARKET WIRE) -- October 6, 2005 -- AVL Global, Inc. (OTC: AVLL) is pleased to announce that it is moving forward with the intended merger between itself and Xian Chongyang Biological Sci-tech Stock Co, Ltd. The merger and share exchange agreements have been signed. Legal council for both companies is now preparing the closing documents which are expected to be signed and the deal concluded before the end of October, 2005.

The Chongyang Group is the manufacturer of a line of herbal medicines and reported sales in excess of $8 million USF with net profits in excess of $2 million USF for the 2004 yearend.

The management of AVL expresses great confidence in the value this merger will bring to our shareholders. It is a major change in focus for AVL but will offer new and major growth opportunities for all shareholders as we venture into this exciting new market.

Additional information will be forthcoming.

Forward Looking Statements

Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from the expected results.

Contact Information

  • FOR FURTHER INFORMATION contact us at: